BRIEF published on 01/20/2025 at 18:05, 1 year 4 months ago Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC Transparency Notification Share Acquisition Atlas Special Opportunities Oxurion Retinal Disease Therapies
BRIEF published on 01/20/2025 at 18:05, 1 year 4 months ago Oxurion reçoit une notification de transparence de la part d'Atlas Special Opportunities LLC Acquisition D'actions Oxurion Opportunités Spéciales Atlas Avis De Transparence Thérapies Pour Les Maladies De La Rétine
PRESS RELEASE published on 01/20/2025 at 18:00, 1 year 4 months ago Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC Oxurion NV receives transparency notification regarding shares ownership from Atlas Special Opportunities, LLC, crossing the 20% threshold. Company engaged in developing ophthalmic therapies Transparency Notification Ophthalmic Therapies Oxurion NV Shares Ownership Belgian Transparency Legislation
PRESS RELEASE published on 01/20/2025 at 18:00, 1 year 4 months ago Oxurion ontvangt transparantiekennisgeving van Atlas Special Opportunities LLC Oxurion NV ontvangt transparantiekennisgeving van Atlas Special Opportunities LLC over aankoop aandelen, voldoet aan Belgische transparantiewetgeving. Oogheelkundig bedrijf gevestigd in Leuven, België Transparantiekennisgeving Oxurion NV Biofarmaceutisch Netvliesaandoeningen Belgische Transparantiewetgeving
BRIEF published on 01/14/2025 at 18:05, 1 year 4 months ago Oxurion reçoit une mise à jour de transparence d'Atlas Special Opportunities LLC Actions Atlas Transparence Biopharmaceutique Oxurion
BRIEF published on 01/14/2025 at 18:05, 1 year 4 months ago Oxurion Receives Transparency Update from Atlas Special Opportunities LLC Actions Transparency Atlas Biopharmaceutical Oxurion
PRESS RELEASE published on 01/14/2025 at 18:00, 1 year 4 months ago Oxurion ontvangt aangepaste transparantiekennisgeving van Atlas Special Opportunities LLC Oxurion NV ontvangt aangepaste transparantiekennisgeving van Atlas Special Opportunities LLC wegens verkoop van aandelen. Leuven biofarmaceutisch bedrijf actief in oftalmologische therapieën Transparantiekennisgeving Oxurion NV Biofarmaceutisch Oftalmologische Therapieën België
PRESS RELEASE published on 01/14/2025 at 18:00, 1 year 4 months ago Oxurion Receives Amended Transparency Notification from Atlas Special Opportunities LLC Oxurion NV announces receiving an amended transparency notification regarding share ownership by Atlas Special Opportunities, LLC, crossing under the 3% threshold Transparency Notification Share Ownership Atlas Special Opportunities LLC Oxurion NV Retinal Disease
BRIEF published on 01/13/2025 at 18:05, 1 year 4 months ago Oxurion Updates Voting Rights Following Convertible Bond Conversion Voting Rights Convertible Bonds Capital Increase Market Opportunities Oxurion
BRIEF published on 01/13/2025 at 18:05, 1 year 4 months ago Oxurion met à jour ses droits de vote suite à la conversion des obligations convertibles Obligations Convertibles Augmentation De Capital Droit De Vote Opportunités De Marché Oxurion
Published on 06/02/2026 at 22:30, 1 hour 18 minutes ago INEO Announces Effective Date of Share Consolidation
Published on 06/02/2026 at 19:40, 4 hours 8 minutes ago Taranis Outlines Four High-Priority Targets Around Thor and Thirty Prospects and Old Mines Located within 6,470 Ha Property
Published on 06/02/2026 at 16:15, 7 hours 33 minutes ago Vulcan Minerals Inc. - Drilling to Resume at Carbonear Zinc-Lead SEDEX project in Newfoundland
Published on 06/02/2026 at 22:35, 1 hour 13 minutes ago Hycroft Delivers $10 Billion NPV from Technical Report at Spot Prices While Advancing High-Grade Brimstone and Vortex Silver Discoveries
Published on 06/02/2026 at 19:50, 3 hours 58 minutes ago Recorded Future Announces Strategic Partnership with Wipro to Deliver AI-Powered Threat Intelligence at Global Enterprise Scale
Published on 06/02/2026 at 19:41, 4 hours 7 minutes ago Avolta prices EUR 400 million of Senior Notes
Published on 06/02/2026 at 19:28, 4 hours 20 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 06/02/2026 at 19:00, 4 hours 48 minutes ago PATRIMOINE ET COMMERCE: INFORMATIONS RELATIVES AU NOMBRE TOTAL DE DROITS DE VOTE ET AU NOMBRE D’ACTIONS COMPOSANT LE CAPITAL SOCIAL AU TITRE DE L’ARTICLE 223-16 DU REGLEMENT GENERAL DE L'AMF
Published on 06/02/2026 at 18:03, 5 hours 45 minutes ago Total number of voting rights and shares making up the share capital at May 31, 2026
Published on 06/02/2026 at 17:42, 6 hours 6 minutes ago Aéroports de Paris SA - Actions et droits de vote au 31 mai 2026
Published on 06/02/2026 at 17:42, 6 hours 6 minutes ago Aéroports de Paris SA - Shares and voting rights as of 31 May 2026
Published on 06/02/2026 at 17:40, 6 hours 8 minutes ago Campus AI entre en phase de réalisation : Eiffage retenu pour le déploiement des infrastructures communes du campus de Fouju. Un marché de plus de 120 millions d’euros.
